Silymarin, a milk thistle seed extract, helps lower elevated blood sugar and lipid levels in diabetics, according to new findings.1
Scientists administered 200 mg of silymarin three times daily for four months to 25 type II diabetes patients, while 26 diabetics received a placebo. Blood levels of fasting glucose, hemoglobin A1c (HbA1c, which reflects long-term glucose control), insulin, total cholesterol, high-density lipoprotein (HDL), low-density lipoprotein (LDL), and triglycerides were measured before the trial and at its conclusion.
Subjects who received silymarin experienced significant reductions in fasting blood glucose, HbA1c, total cholesterol, LDL, and triglycerides, while fasting blood glucose, total cholesterol, triglycerides, and HbA1c increased in the placebo group.
By decreasing glucose and lipid levels, silymarin may thus play an important role in the management of type II diabetes.